AMPH (STOCKS)
Amphastar Pharmaceuticals, Inc.
$20.180000
+0.200000 (+1.00%)
Prev close: $19.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yong Feng Zhang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $858.41M
- Employees
- 2,028
- P/E (TTM)
- 11.71
- P/B (TTM)
- 1.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $730.02M |
| Benefits Costs and Expenses | $628.00M |
| Cost Of Revenue | $381.91M |
| Costs And Expenses | $628.00M |
| Gross Profit | $348.11M |
| Nonoperating Income/Loss | -$12.26M |
| Operating Expenses | $233.82M |
| Research and Development | $94.57M |
| Other Operating Expenses | $139.25M |
| Operating Income/Loss | $114.29M |
| Income/Loss From Continuing Operations After Tax | $78.55M |
| Income/Loss From Continuing Operations Before Tax | $102.02M |
| Income Tax Expense/Benefit | $23.48M |
| Net Income/Loss | $78.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $78.55M |
| Net Income/Loss Available To Common Stockholders, Basic | $78.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.74 |
| Diluted Earnings Per Share | $1.69 |
| Basic Average Shares | 90,679,000 |
| Diluted Average Shares | 92,668,000 |
| Assets | $1.74B |
| Current Assets | $630.95M |
| Inventory | $179.91M |
| Other Current Assets | $451.04M |
| Noncurrent Assets | $1.11B |
| Fixed Assets | $316.06M |
| Other Non-current Assets | $796.75M |
| Liabilities | $975.61M |
| Current Liabilities | $263.21M |
| Accounts Payable | $28.93M |
| Wages | $30.52M |
| Other Current Liabilities | $203.76M |
| Noncurrent Liabilities | $712.40M |
| Equity | $768.16M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $768.16M |
| Liabilities And Equity | $1.74B |
| Net Cash Flow From Operating Activities | $184.61M |
| Net Cash Flow From Operating Activities, Continuing | $184.61M |
| Net Cash Flow From Investing Activities | -$52.05M |
| Net Cash Flow From Investing Activities, Continuing | -$52.05M |
| Net Cash Flow From Financing Activities | -$96.46M |
| Net Cash Flow From Financing Activities, Continuing | -$96.46M |
| Exchange Gains/Losses | -$172.00K |
| Net Cash Flow | $35.93M |
| Net Cash Flow, Continuing | $36.10M |
| Comprehensive Income/Loss | $78.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $78.00M |
| Other Comprehensive Income/Loss | $47.58M |
| Other Comprehensive Income/Loss Attributable To Parent | -$543.00K |